Your cart is empty

Synthetic Heptapeptide Research Compound
Selank is a synthetic peptide studied in laboratory settings for its interaction with neuroregulatory pathways involved in stress and cognitive signaling. Research often focuses on its influence on neurotransmitter systems, receptor activity, and overall modulation of central nervous system communication in controlled experimental models.
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
Selank is a synthetic heptapeptide derived from the endogenous tetrapeptide tuftsin with structural modifications for enhanced stability in experimental systems. It is developed for controlled laboratory research involving neuropeptide signaling pathways.
In scientific literature, Selank is studied in models examining neurotransmitter-associated signaling frameworks, receptor-mediated regulatory systems, and central nervous system pathway interaction under in vitro and preclinical research conditions.
Third-party tested for purity, identity, quantity.
Selank is a modified peptide analogue evaluated in research focused on neuropeptide signaling and central regulatory pathway interaction. Experimental studies examine its interaction within neurotransmitter-associated frameworks and receptor-mediated signaling systems under controlled laboratory conditions.
Research publications have explored its signaling profile and pathway-level regulatory characteristics within structured experimental environments.
Selank was developed through investigations into synthetic analogues of tuftsin designed to enhance stability and signaling properties. Research expanded into neuropeptide interaction models and central signaling system frameworks within laboratory environments.
Subsequent studies documented its regulatory pathway interaction and peptide signaling behavior in experimental research systems.
Laboratory investigations into Selank have focused on neuropeptide signaling models and receptor-mediated pathway interaction systems. Research frameworks evaluate peptide stability, central regulatory dynamics, and neurotransmitter-associated signaling mechanisms under controlled in vitro and preclinical conditions.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each vial contains 10mg of lyophilized Selank. Independent third-party testing verifies purity, identity, and net content per batch.
The vial contains only the peptide preparation. Any laboratory materials required for experimental procedures must be sourced separately.
Duration depends entirely on research protocol, storage conditions, and laboratory application.
Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats.
PubMedThe Influence of Selank on the Level of Cytokines Under the Conditions of "Social" Stress. Curr Rev Clin Exp Pharmacol 16(2):169–173.
PubMedSelank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating BDNF Content in the Hippocampus and Prefrontal Cortex in Rats.
PubMedThe occurrence of putative cognitive enhancing research peptides in seized pharmaceutical preparations: An incentive for controlling agencies to prepare for future encounters of the third kind. Drug Test Anal 12(1):63–73.
PubMedRelated

Studied in metabolic research for its effects on glucose regulation, appetite signaling, and energy balance.
From$180.00

Dual incretin receptor agonist studied for glucose regulation, metabolic signaling, and weight pathway research
From$10.00

Immune-modulating peptide studied for T-cell signaling and immune system regulatory pathway research
From$70.00

GHRH analog studied for growth hormone regulation and metabolic pathway signaling research
From$95.00